UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the knowledge gaps and bring regulators on board? Regulators and medical professionals have repeatedly called for more [...]
Cancer patients using cannabis-based medicinal products (CBMPs) experience significant improvements in pain management, sleep quality, and anxiety levels, according to new research published in the Journal of Pain & Palliative Care Pharmacotherapy. The six-month observational study, which analysed data from 168 cancer patients prescribed cannabis oil [...]
It can help balance your sleep cycle and kick insomnia to the curb. Sweet dreams could be just a prescription away!
The post Tossing and turning all night? Prescription cannabis might just be your snooze button in plant form! appeared first on I Am Billy.
Let’s be real – prescription pain meds like opioids and NSAIDs come with a laundry list of side effects (hello, addiction risk and stomach issues). Prescription cannabis, on the other hand, offers pain relief without the major downsides. While it’s not a magic cure-all, it provides a natural, plant-based alternative with fewer risks when used […]
The post Prescription Cannabis vs. Traditional Treatments: Which Wins? appeared first on I Am Billy.
Pain isn’t just physical – it messes with your head, too. Luckily, cannabis does double duty by not only soothing pain but also lowering stress and improving sleep. Studies suggest that CBD helps regulate cortisol (the stress hormone), meaning you might just feel less anxious and more zen. And since better sleep = better healing, […]
The post Prescription Cannabis – Less Stress, Better Sleep, and a Happier You ? appeared first on I Am Billy.
Here’s how it works: • Your body has a built-in endocannabinoid system (ECS) – a fancy network of receptors that helps regulate things like sleep, mood, appetite, and pain. • Enter cannabinoids (the active compounds in cannabis), which interact with the ECS to reduce inflammation and chill out pain signals. • The dynamic duo of prescription cannabis – […]
The post Prescription Cannabis – It’s got some serious Pain-Fighting Superpowers thanks to its analgesic (pain-relieving) and anti-inflammatory properties. appeared first on I Am Billy.
Back pain – it’s the ultimate mood killer. Whether it’s from hunching over your laptop like a goblin, lifting something way heavier than you should have, or just existing in a body that insists on rebelling against you, chronic back pain can make everyday life a total drag. While traditional treatments like physical therapy and […]
The post A Highly Effective Solution: How Medical Cannabis Can Chill Out Your Back Pain appeared first on I Am Billy.
Turns out, cannabinoids aren’t just for oral administration – they might also have some serious skin-saving superpowers! With their well-documented anti-inflammatory effects, these compounds are stepping into the spotlight as potential game-changers for wound healing. A deep dive into the research scene explored how cannabinoids interact with the body’s natural wound repair process. And while […]
The post Cannabinoids & Wound Healing: appeared first on I Am Billy.
Well, that depends on how you take it! If you’re inhaling it (vaping, that is and not trying to summon a genie), expect the effects to hit within minutes and reach their peak in about 30-60 minutes. Now, if you’re going the oil route, buckle up for a slightly longer ride- anywhere from 45 to […]
The post How Fast Does Medical Cannabis Kick In? appeared first on I Am Billy.
Doctors and researchers are still squinting through the smoke when it comes to understanding how cannabis actually works as a medical treatment. But a new National Cannabis Study might finally bring some clarity—by tracking around 10,000 patients and their responses to cannabis-based therapies. This study is part of a larger Cannabis and Health Research Initiative, […]
The post New Research Tools Could Clear Some of the Haze Around Medical Cannabis appeared first on I Am Billy.
Switzerland has approved a draft proposal to establish a fully commercial adult-use cannabis market, putting the country in pole position to be the first in Europe to do so. A new draft for a federal law, which would enable citizens to legally ‘grow, buy, possess and [...]
Having access to medical cannabis helps mothers be more present parents, increases their patience with their children, and enables them to better manage their own health needs, according to the results of a study funded by the New Zealand government. The study, published in the journal [...]
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors, as its first products were made available on prescription for patients earlier this month. After five years and over £10 million in investment, Dalgety has become the first facility in the [...]
A parliamentary committee in Switzerland has put forward plans that would legalise the possession and use of cannabis. The proposal would allow the sale of cannabis products to Swiss citizens over 18 years of age and for a maximum of three plants to be grown at [...]
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream healthcare has faced significant hurdles. While private clinics have provided access to cannabis-based medicines (CBMPs), many healthcare professionals remain sceptical, largely due to outdated perceptions, limited clinical education, and a lack [...]
A new research partnership between the University of Malta and the Authority for the Responsible Use of Cannabis will study the differences between illegal cannabis and that which is accessed through licensed associations. The agreement, which will see the University of Malta and the ARUC collaborate [...]
Europe’s first patient-led event will return next month with a focus on the medicinal use of cannabis in chronic neurodegenerative diseases. Following a successful launch in Madrid in October, We, The Patients, will host its first event in Switzerland on 1 March at the Resident Zürich [...]
Researchers from Cleveland Clinic have announced plans for a drug trial that will study if a novel psychedelic drug can help treat postnatal depression. The drug, called RE104, is almost identical in makeup to psilocybin, with the main difference being the length of time patients experience [...]
What is the Care Quality Commission (CQC)? The Care Quality Commission (CQC) is the UK’s independent regulator of health and social care services. It exists to ensure that clinics, hospitals, and other healthcare providers are following all relevant guidelines and meet essential standards of safety, effectiveness, [...]
Via Business of Cannabis Spain’s long-awaited medical cannabis program has finally taken a step forward as a draft of a Royal Decree has been sent to the European Union for approval. If approved, this should give Spanish patients legal access to medical cannabis for the first [...]
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van Heerden, a clinical doctor at Releaf with a background in emergency medicine, believes medical cannabis should be considered a first-line treatment option rather than an alternative. The Opioid Crisis: Over 500,000 [...]
New findings, from the largest study of its kind, suggest cannabis use may be linked to a decline in working memory among young adults. The new study published in JAMA Network Open explores the effects of both recent and lifetime cannabis use on brain function during [...]
Tetrahydrocannabinolic acid (THCa) is a non-psychoactive cannabinoid found abundantly in raw cannabis plants. Unlike its decarboxylated form, tetrahydrocannabinol (THC), THCa does not produce intoxicating effects. This distinction is crucial for medical cannabis patients, healthcare professionals, and industry experts seeking to understand the therapeutic potential and legal considerations of THCa, particularly within the United Kingdom. Biochemical Nature of THCa THCa serves as the acidic precursor to THC. In its natural state, cannabis plants synthesise cannabinoids in their acidic forms, with THCa being predominant. When exposed to heat through processes like smoking, vaping, or cooking—a reaction known as decarboxylation—THCa loses a carboxyl group, transforming into THC, the compound responsible for cannabis’s psychoactive effects. Therapeutic Potential of THCa Emerging research suggests that THCa may offer several health benefits: Psychoactivity of THCa In its raw form, THCa is non-psychoactive and does not produce the “high” associated with THC consumption. This non-intoxicating nature makes it an attractive option for patients seeking therapeutic benefits without cognitive impairment. However, it’s essential to note that when THCa is heated, it converts into THC, thereby gaining psychoactive properties. Applications of THCa Given its potential therapeutic properties and non-psychoactive nature, THCa is utilised in various forms: Legal Status of THCa in the UK The Advisory Council on the Misuse of Drugs (ACMD) has provided insights into the behaviour and control status of tetrahydrocannabinolic acid (THCa) in its report on consumer cannabidiol (CBD) products. The report highlights that THCa does not significantly convert to Δ9-tetrahydrocannabinol (Δ9-THC) within the human body after ingestion. Additionally, while THCa can decarboxylate into Δ9-THC at temperatures below 100°C, this process requires prolonged exposure; at room temperature, the conversion is negligible. These findings suggest that THCa’s limited potential for in vivo conversion to psychoactive Δ9-THC may influence its regulatory status. The legal framework surrounding THCa in the United Kingdom is complex. While THCa itself is non-psychoactive, it is closely regulated due to its potential to convert into THC when heated. This conversion raises concerns for law enforcement and regulatory bodies. According to the UK’s Misuse of Drugs Regulations 2001, THC is a controlled substance, and any product containing cannabinoids that can be converted into THC may fall under this regulation. In practice, this means that while THCa is not explicitly listed as a controlled substance, its presence in products intended for consumption could be subject to legal scrutiny, especially if there’s a likelihood of decarboxylation into THC. Therefore, products containing THCa are subject to stricter controls and are generally less accessible than CBD products. In the United Kingdom, cannabis and its derivatives are primarily regulated under the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001. Cannabis is classified as a Class B controlled drug, making it unlawful to possess, supply, produce, import, or export without appropriate licensing. The legislation defines cannabis to include any part of the plant, excluding mature stalks, fibre, and seeds. Additionally, cannabinoids such as THC are specifically controlled substances. While cannabidiol (CBD) in its pure form is not controlled, products containing other cannabinoids, including THCa, are subject to regulation. The Home Office acknowledges that due to challenges in isolating CBD from other cannabinoids, consumer CBD products may contain varying amounts of controlled substances like THC and THCa. Therefore, any product containing controlled cannabinoids is classified as a Class B controlled drug unless it meets the “exempt product” criteria outlined in Regulation 2 of the Misuse of Drugs Regulations 2001. Exempt Product Criteria For a product to be considered exempt, it must fulfil specific conditions: If a product meets all these criteria, it is not subject to the prohibitions on importation, exportation, production, supply, and possession under the Misuse of Drugs Act 1971. Conclusion THCa represents a promising cannabinoid with potential therapeutic benefits for various medical conditions. Its non-psychoactive nature makes it suitable for patients seeking relief without the intoxicating effects of THC. The sale and distribution of THCa products in the UK occupy a legally ambiguous space. While businesses continue their operations, the potential for legal challenges remains due to the intricate regulatory framework governing cannabis and its derivatives. It is imperative for businesses and consumers to stay informed and consult legal experts when navigating this evolving landscape. References Drug Licensing Factsheet (Cannabis, CBD & Other Cannabinoids) Consumer CBD products report – ACMD Is THCa legal in the UK – r/LegalAdviceUK – Reddit The Legal Weed No One’s Talking About – Vice Disclaimer The information provided in this article is intended for educational and informational purposes only and should not be construed as legal or medical advice. While efforts have been made to ensure the accuracy of the content, however the legal framework surrounding THCa is complex and subject to change. Readers are advised to consult with qualified legal professionals to obtain guidance tailored to their specific circumstances. The authors and publishers disclaim any liability arising from the use or misuse of the information contained herein.
The post THCa is it legal? first appeared on PatientsCann UK.
A large-scale study of hospital admissions in Ontario, Canada has shown that there are higher incidences of schizophrenia in patients with cannabis use disorder (CUD) when compared to the rest of the population. Researchers based in Ontario and Berlin studied data from hospital admissions between 2006 [...]
Via Business of Cannabis The first parliamentary debate on medical cannabis in the UK under the new Labour administration has shattered hopes of a more progressive stance on reform. Despite impassioned speeches from members of various parties, unanimously calling for the UK’s ‘patchwork’ cannabis regulation to [...]
Since the legalisation of medical cannabis in the UK in 2018, patients have faced numerous challenges in accessing and utilising cannabis-based medicinal products (CBMPs). Despite legal provisions, the landscape remains fraught with limited support, societal stigma, and complex legal hurdles. Organisations like Seed Our Future play a crucial role in advocating for patients’ rights and providing necessary support. Challenges in Legal Support The legal framework surrounding medical cannabis in the UK is complex, creating numerous obstacles for patients seeking treatment. While specialist doctors are legally permitted to prescribe cannabis-based medicinal products (CBMPs), access remains severely limited, forcing many patients to navigate a difficult and often expensive system. One of the primary challenges is the scarcity of NHS prescriptions for medical cannabis. Despite its legal status, NHS doctors rarely prescribe CBMPs, leaving most patients with no choice but to turn to private clinics. However, private prescriptions can be prohibitively expensive, making access to medical cannabis a privilege rather than a right for many who need it. Legal uncertainties further complicate matters. Many patients struggle to understand the exact legalities surrounding the possession and use of their prescribed cannabis, particularly in public spaces or workplaces. Questions about where they can legally consume their medication, how employers should accommodate their needs, and whether they risk law enforcement scrutiny add to the confusion and anxiety patients face daily. A significant barrier to proper legal support is the widespread lack of awareness. Many patients, healthcare professionals, and even service providers do not fully understand the legal rights and regulations governing medical cannabis use. This gap in knowledge often results in patients being misinformed or hesitant to assert their rights, while some service providers may be unwilling to support patients prescribed CBMPs simply due to uncertainty about the legal implications. Societal Stigma Despite its legalisation for medical use, cannabis continues to carry a deep-rooted stigma due to its long-standing association with recreational use and illegality. This stigma affects patients in several ways, often leading to unnecessary challenges and discrimination. One of the most significant issues is public perception. Many medical cannabis patients face judgment or misunderstanding from the public, which can result in social isolation or even outright discrimination. The misconception that all cannabis use is recreational or illicit contributes to this negative outlook, making it harder for patients to openly discuss their treatment or seek support. Employment is another area where stigma creates difficulties. Despite legal protections, employees who use medical cannabis may encounter prejudice or unfair treatment in the workplace. Employers who lack awareness or understanding of medical cannabis laws may view its use as problematic, even when it is prescribed for legitimate health conditions. This can lead to unnecessary workplace conflicts, job insecurity, or even wrongful dismissal. Stigma also extends into the healthcare system itself. Some healthcare professionals remain hesitant to prescribe cannabis-based medicinal products (CBMPs) due to lingering biases or a lack of education on the subject. This reluctance can leave patients struggling to access the treatment they need, forcing them to seek expensive private prescriptions or, in some cases, go without medication entirely. Overcoming these societal barriers requires greater public education, stronger legal protections, and a shift in cultural attitudes towards medical cannabis. Legal Support Resources For patients seeking legal assistance, several law firms and organisations specialise in areas pertinent to medical cannabis use: Organisation/Law Firm Specialties Overview Seed Our Future Legislative Research, Education, Patient Support A national campaign organisation dedicated to legislative and historical research, education through open-source reports, lectures, and articles. They provide support to UK citizens affected by unjust laws and offer assistance to medical cannabis patients facing legal and discrimination cases. Ringrose Law Medical Negligence, Discrimination, and more Offers services in medical negligence and criminal defense, pertinent to medical cannabis patients facing related legal challenges. Their team is equipped to handle cases involving medical malpractice and criminal allegations. While our current list of law firms and organisations offering legal support to medical cannabis patients in the UK is limited, we anticipate its growth as more legal professionals gain a comprehensive understanding of medical cannabis law. As awareness increases and the legal landscape evolves, we are committed to expanding our directory to better serve patients’ needs. We encourage lawyers and solicitors with relevant expertise to contact us, so we can include their services in our list and collectively enhance support for the medical cannabis community. Medical cannabis in the UK remains complex due to limited support and persistent stigma. Organisations like Seed Our Future are essential in advocating for patient rights, providing education, and challenging unjust laws. Supporting such initiatives is crucial for fostering a more informed and compassionate approach to medical cannabis use. Note: This article is for informational purposes only and should not be considered legal advice. For specific legal concerns, consult with a qualified legal professional. Medical Cannabis Employment Medical Cannabis Housing Medical Cannabis Driving Seed Our Future Ringrose Law
The post Legal Support for Medical Cannabis Patients in the UK first appeared on PatientsCann UK.
Researchers from Brazil have published a detailed study showing significant improvements in a patient living with late-stage Parkinsons Disease after just 63 days of treatment with cannabis oil. The patient, a 77 year old man, was diagnosed with Parkinson’s Disease 22 years ago. Due to the [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
